D. Western Therapeutics Institute, Inc. provided consolidated earnings guidance for the year ending December 31, 2020. For the year, the company expects net sales of JPY 310 million, operating loss of JPY 390 million, loss attributable to owners of the parent of JPY 340 million and loss per share of JPY 12.94.